Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.69 USD
Change Today +0.56 / 4.62%
Volume 632.1K
LXRX On Other Exchanges
Symbol
Exchange
LXRX is not on other exchanges.
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey L. Wade J.D.

Chief Financial Officer and Executive Vice President of Corporate & Administrative Affairs,Lexicon Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

50$1,115,349
As of Fiscal Year 2014

Background*

Mr. Jeffrey L. Wade, J.D. has been the Chief Financial Officer and Executive Vice President of Corporate & Administrative Affairs of Lexicon Genetics Inc. (also known as Lexicon Pharmaceuticals, Inc) since May 2010 and February, 2015 respectively. Mr. Wade served as an Executive Vice President of Corporate Development at Lexicon Pharmaceuticals, Inc., from May 2010 to February 2015. Mr. Wade served as an Executive Vice President and General Counsel of Lexicon Genetics ...

Read Full Background

Corporate Headquarters*

8800 Technology Forest Place
The Woodlands, Texas 77381

United States

Phone: 281-863-3000
Fax: 281-863-8088

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

JD
The University of Texas System
BA
The University of Texas System

Other Affiliations*

Annual Compensation*

Salary$393,000
Bonus$141,480
Total Annual Compensation$534,480

Stock Options*

Restricted Stock Awards$141,040
All Other Compensation$7,066
Exercisable Options1,983,297
Unexercisable Options578,703
Total Number of Options2,562,000

Total Compensation*

Total Annual Cash Compensation$541,546
Total Short Term Compensation$534,480
Other Long Term Compensation$148,106
Total Calculated Compensation$1,115,349
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $12.69 USD +0.56

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
$1.1M
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
$921.3K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.